Obviously, IGF-1 R is more important than TSHR in the treatment of GO because the inhibition of IGF-1 R with IGF-1 R antibody (Teprolumumab) had the best therapeutic effect ever seen [57,58]. The gene discussed is TSHR; the disease is geroderma osteodysplastica.